Levetiracetam Alter

Levetiracetam, the active ingredient in Levetiracetam Alter, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable batch‑to‑batch consistency for seizure‑management therapy. The company also offers regulatory support and secure logistics to ensure timely delivery across regions.

Levetiracetam is used to control seizure activity in various epilepsy syndromes. - Partial seizures: reduces frequency of focal onset seizures in patients with epilepsy. - Generalized tonic-clonic seizures: helps prevent convulsive episodes in individuals with generalized epilepsy. - Myoclonic seizures: decreases myoclonic jerks in patients with juvenile myoclonic epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as neutropenia - Suicidal thoughts or behavior - Severe depression or mood changes - Persistent rash or skin eruptions

When prescribing Levetiracetam, clinicians should consider several safety measures. - Renal function: adjust dose in patients with impaired clearance. - Psychiatric monitoring: watch for mood changes, irritability, depression. - Discontinuation: taper gradually under medical supervision to avoid seizure worsening. - Pregnancy: safety not established; weigh benefits against potential risks. - Concomitant CNS depressants: may enhance sedation; monitor closely. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital, or rifampin: strong enzyme inducers that markedly lower levetiracetam plasma levels. - Oral contraceptives: levetiracetam may reduce hormonal contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam concentrations, necessitating dose review. - Alcohol or other CNS depressants: additive sedation, requiring careful observation.